论文部分内容阅读
1994年6月至1998年6月,我们应用吡柔比星(ＴＨＰ)采用肝动脉化疗栓塞(ＨＡＣＥ)或灌注药物(ＨＡＩＣ)共介入治疗了100例中晚期肝癌患者,并对其临床疗效进行了观察比较,现报告如下。1 材料与方法11 病例选择100例不能手术切除的肝癌住院患者,且经临床表现,Ｂ超或ＣＴ检查,血Ａ
From June 1994 to June 1998, we applied percutaneous injection of pirarubicin (THP) to hepatocellular chemotherapy embolization (HACE) or perfusion drug (HAIC) for the treatment of 100 patients with advanced liver cancer and their clinical efficacy. Observed and compared, the report is as follows. 1 Materials and Methods 11 Cases selected 100 cases of inoperable liver cancer patients, and after clinical manifestations, B- or CT examination, blood A